Nonprofit psychedelic research organisation Usona Institute has completed its submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) concerning its psilocybin candidate for major depressive disorder (MDD), Psychedelic Alpha understands. It means it’s the second psychedelic NDA under review by the agency at present…
EvanderNovember 2, 20261 min read
Curated by Paradise Farmers Market
Read the full story
Continue reading at Psychedelic Alpha
Originally reported by Evander at Psychedelic Alpha
Paradise Farmers Market curates content for educational purposes.
